The looming health crisis; notoriously 'unwanted' business; recent (cool) breakthroughs in antibiotics; how tech may help revive the lost art of antibiotics discovery; NOT MEDICAL ADVICE.
"according to a World Health Organization report released in 2021, none of the 43 antibiotics currently in development "adequately address the problem of drug resistance"" Wow 😬
Thank you for your comment, Eshan. Yes, from what I have read and talked about with industry KOLs, it seems the situation is quite concerning, especially in the area of gram-negative infections. Here is a brief but insightful post by Cris De Savi (former VP of Drug Discovery and Kymera) ot have a bit more context on the issue:
But in fact, there is a lot of indeapth articles and reports on this issue, I am just scratching the surface in this newsletter, and trying to bring more attention.
Insightful article, Andrii!
"according to a World Health Organization report released in 2021, none of the 43 antibiotics currently in development "adequately address the problem of drug resistance"" Wow 😬
Thank you for your comment, Eshan. Yes, from what I have read and talked about with industry KOLs, it seems the situation is quite concerning, especially in the area of gram-negative infections. Here is a brief but insightful post by Cris De Savi (former VP of Drug Discovery and Kymera) ot have a bit more context on the issue:
Are We Keeping Up With Antimicrobial Resistance? https://www.biopharmatrend.com/post/464-are-we-keeping-up-with-resistance/
But in fact, there is a lot of indeapth articles and reports on this issue, I am just scratching the surface in this newsletter, and trying to bring more attention.
Thank you for sharing the link and for the work you do!
You are welcome, Eshan.